Vandomme A , Fréville A , Cailliau K , Kalamou H , Bodart JF , Khalife J , Pierrot C .

	Figure 1. Molecular cloning and sequence analysis of PfPTPA. (a) Analysis of PfPTPA (PF3D7_1430100) amino acid sequence. PfPTPA was aligned with the human PTPA (CAA60163.1) using ClustalW Multiple Alignment (BioEdit). The identical residues are highlighted in black and similar residues in grey. Stars symbolized amino acids involved in PTPA/PP2A interaction in human; (b) Phylogenic tree of the PTPA family. A maximum likelihood tree was generated from the 21 PTPA sequences using MEGA5 [45] under the JTT + G + I model with 100 bootstrap repetitions. Outgroups are formed by PP2A inhibitor 2 orthologs (I2PP2A, outgroup 1) PP1 inhibitor 2 orthologs (I2PP1, outgroup 2) and PP1 inhibitor 3 orthologs (I3PP1, outgroup 3); (c) Crystal structure of HuPTPA (PDB: 2IXM). Amino acid residues involved in PTPA/PP2A interaction are shown in red; (d) Structural model of PfPTPA based on the crystal structure of HuPTPA (PDB: 2IXM) using the ModBase server [46]. Amino acid residues studied in this work for the PTPA/PP2A interaction are shown in red.
	Figure 2. Expression of pfptpa and pfpp2a gene by Plasmodium falciparum and localization (a) Representation of pfptpa (black bars) and pfpp2a (grey bars) RNA expression during the erythrocytic life cycle of P. falciparum. Data plotted are from PlasmoDB [44]; (b) Schematic representation of the pARL2-pfptpa-gfp and pARL2-pfpp2a-gfp vectors used for episomal expression of both PfPTPA and PfPP2A; (c) The expression of both proteins was checked by western blotting with anti-GFP antibodies after separation on 15% SDS-PAGE. Lane 1 represents the extract of wild type parasites. Lane 2 and 3 represent extracts from PfPTPA and PfPP2A transfected parasites respectively. Expression and localization of PfPTPA-GFP (d) and PfPP2A-GFP (e) throughout the erythrocytic cell cycle of P. falciparum were analyzed by fluorescence microscopy after transfection as described under experimental section.
	Figure 3. Interaction studies of PfPTPA to PP2A. (a) Binding of PfPTPA with PfPP2A in Xenopus oocyte. Co-immunoprecipitation of the PfPTPA-PfPP2A complex with anti-His antibodies (recognizing recombinant PfPTPA tagged with 6-His) (lanes 2 and 3) from microinjected Xenopus extracts. The anti-mouse IgG antibody (lane 1) was used as a control. Immunoprecipitates from Xenopus oocytes microinjected with water (−) or PfPTPA (+) were eluted and separated by SDS-PAGE and transferred to nitrocellulose membrane. Immunoblot analysis was performed with anti-His antibodies (recognizing PfPTPA) (upper panel) or anti-Myc antibodies (recognizing PfPP2A) (lower panel); (b) Interaction of PfPTPA with HuPP2A in vitro assessed by ELISA based assay. Increasing quantities of biotinylated recombinant PfPTPA were added to wells coated with human PP2A (100 ng/well) or BSA (100 ng/well) as a negative control. Results are means ± SEM of two independent experiments performed in duplicate (stars (*) represent significant differences p = 0.01); (c) Binding of mutated PfPTPA with PfPP2A in Xenopus oocytes. Co-immunoprecipitation experiment of the PfPTPA-PfPP2A complexes with anti-His antibodies (recognizing recombinant wild type and mutated PfPTPA) (upper panel) or with anti-Myc antibodies (recognizing PfPP2A) (lower panel) from microinjected Xenopus oocytes. Immunoprecipitates from Xenopus oocytes microinjected with water, WT or mutated PfPTPA were eluted and separated by SDS-PAGE and transferred to nitrocellulose membrane. Immunoblot analysis was performed with anti-His or anti-Myc antibodies.
	Figure 4. Effect of wild type and mutated PfPTPA proteins on PP2A activity. The capacity of PfPTPA (WT or mutated) to regulate HuPP2A was assessed using pNPP activity tests. The human PP2A activity was measured at 405 nm by the release of p-nitrophenol after incubation with different concentration of recombinant WT or mutated PfPTPA proteins. Results presented as fold change in human PP2A activity are means ± SEM of three independent experiments (stars (*) represent significativity p = 0.01).
	Figure 5. Genetic studies of pfptpa and pfpp2a. (a,b) Gene-targeting construct for gene disruption by single homologous recombination using the pCAM-BSD, and the locus resulting from integration of the knockout pfptpa (a) or pfpp2a (b) construct. (c,d) Analysis of pCAM-BSD-pfptpa (c) and pCAM-BSD-pfpp2a (d) transfected 3D7 culture by PCR; lanes 1–3 correspond to DNA extracted from transfected parasites; lanes 4–6 correspond to DNA extracted from wild type parasites. Lanes 1 and 4 represent the detection of the full length wild type locus (PCR with p9-p8 and p31-p30 respectively); lanes 2 and 5 represent the detection of episomal DNA (PCR with p10 and p11); and lanes 3 and 6 represent the detection of integration of the insert (PCR with p9-p11 and p31-p11 respectively).
	Figure 6. Inhibition of G2/M transition of Xenopus oocytes by PfPTPA. (a) Percentage of GVBD induced by the progesterone (PG), PfPTPA or the microinjection of PfPTPA followed by PG incubation; (b) Percentage of GVBD induced by PG incubation after microinjection of different amount of PfPTPA; (c) Binding of PfPTPA with XePP2A in Xenopus oocytes. Co-immunoprecipitation experiment of the PfPTPA-XePP2A complex with anti-His antibodies (recognizing recombinant PfPTPA tagged with 6-His) (lanes 2 and 3) from microinjected Xenopus oocytes. The anti-mouse IgG antibody (lanes 1) was used as a control. Immunoprecipitates from Xenopus oocytes microinjected with water (−) or PfPTPA (+) were eluted, separated by SDS-PAGE and transferred to nitrocellulose membrane. Immunoblot analysis was performed with anti-His antibodies (recognizing PfPTPA) (upper panel) or anti-XePP2A antibodies (lower panel); (d) Effect of PfPTPA on progesterone-dependent GVBD in Xenopus oocytes. Percentage of GVBD induced by PG after the microinjection of 10 ng of PfPTPA WT or mutated (n = 2).

Aurrecoechea, PlasmoDB: a functional genomic database for malaria parasites. 2009, Pubmed

Aurrecoechea, PlasmoDB: a functional genomic database for malaria parasites. 2009, Pubmed
Azzi, Purification of a 15-kDa cdk4- and cdk5-binding protein. 1994, Pubmed
Bernal, Regulation of fission yeast morphogenesis by PP2A activator pta2. 2012, Pubmed
Bhattacharyya, Plasmodium falciparum protein phosphatase type 1 functionally complements a glc7 mutant in Saccharomyces cerevisiae. 2002, Pubmed
Blisnick, Protein phosphatase 1, a Plasmodium falciparum essential enzyme, is exported to the host cell and implicated in the release of infectious merozoites. 2006, Pubmed
Bollen, The extended PP1 toolkit: designed to create specificity. 2010, Pubmed
Bowyer, Global profiling of proteolysis during rupture of Plasmodium falciparum from the host erythrocyte. 2011, Pubmed
Cayla, Molecular cloning, expression, and characterization of PTPA, a protein that activates the tyrosyl phosphatase activity of protein phosphatase 2A. 1994, Pubmed
Cayla, Isolation and characterization of a tyrosyl phosphatase activator from rabbit skeletal muscle and Xenopus laevis oocytes. 1990, Pubmed , Xenbase
Chao, Structure and mechanism of the phosphotyrosyl phosphatase activator. 2006, Pubmed
Daher, Regulation of protein phosphatase type 1 and cell cycle progression by PfLRR1, a novel leucine-rich repeat protein of the human malaria parasite Plasmodium falciparum. 2006, Pubmed , Xenbase
Dobson, Characterization of a unique aspartate-rich protein of the SET/TAF-family in the human malaria parasite, Plasmodium falciparum, which inhibits protein phosphatase 2A. 2003, Pubmed
Dobson, A novel tetratricopeptide repeat (TPR) containing PP5 serine/threonine protein phosphatase in the malaria parasite, Plasmodium falciparum. 2001, Pubmed
Dobson, Characterization of protein Ser/Thr phosphatases of the malaria parasite, Plasmodium falciparum: inhibition of the parasitic calcineurin by cyclophilin-cyclosporin complex. 1999, Pubmed
Fardilha, The physiological relevance of protein phosphatase 1 and its interacting proteins to health and disease. 2010, Pubmed
Fernandez-Pol, A bacterial phosphatase-like enzyme of the malaria parasite Plasmodium falciparum possesses tyrosine phosphatase activity and is implicated in the regulation of band 3 dynamics during parasite invasion. 2013, Pubmed
Ferrell, Xenopus oocyte maturation: new lessons from a good egg. 1999, Pubmed , Xenbase
Fréville, Plasmodium falciparum encodes a conserved active inhibitor-2 for Protein Phosphatase type 1: perspectives for novel anti-plasmodial therapy. 2013, Pubmed , Xenbase
Fréville, Plasmodium falciparum inhibitor-3 homolog increases protein phosphatase type 1 activity and is essential for parasitic survival. 2012, Pubmed
Götz, Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. 1998, Pubmed
Guttery, A unique protein phosphatase with kelch-like domains (PPKL) in Plasmodium modulates ookinete differentiation, motility and invasion. 2012, Pubmed
Hendrickx, Docking motif-guided mapping of the interactome of protein phosphatase-1. 2009, Pubmed
Jeong, PP2A function toward mitotic kinases and substrates during the cell cycle. 2013, Pubmed
Jiang, Regulation of the cell cycle by protein phosphatase 2A in Saccharomyces cerevisiae. 2006, Pubmed
Jordens, The protein phosphatase 2A phosphatase activator is a novel peptidyl-prolyl cis/trans-isomerase. 2006, Pubmed
Junttila, CIP2A inhibits PP2A in human malignancies. 2007, Pubmed
Kinoshita, Distinct, essential roles of type 1 and 2A protein phosphatases in the control of the fission yeast cell division cycle. 1990, Pubmed
Kong, Alpha4 is an essential regulator of PP2A phosphatase activity. 2009, Pubmed
Krasinska, Protein phosphatase 2A controls the order and dynamics of cell-cycle transitions. 2011, Pubmed , Xenbase
Kuhn, Trafficking of the phosphoprotein PfCRT to the digestive vacuolar membrane in Plasmodium falciparum. 2010, Pubmed
Kumar, Post-translational generation of constitutively active cores from larger phosphatases in the malaria parasite, Plasmodium falciparum: implications for proteomics. 2004, Pubmed
Kumar, Characterisation and expression of a PP1 serine/threonine protein phosphatase (PfPP1) from the malaria parasite, Plasmodium falciparum: demonstration of its essential role using RNA interference. 2002, Pubmed
Kumar, Plasmodium falciparum calcineurin and its association with heat shock protein 90: mechanisms for the antimalarial activity of cyclosporin A and synergism with geldanamycin. 2005, Pubmed
Lee, The B56gamma3 regulatory subunit of protein phosphatase 2A (PP2A) regulates S phase-specific nuclear accumulation of PP2A and the G1 to S transition. 2010, Pubmed
Leulliot, Crystal structure of the PP2A phosphatase activator: implications for its PP2A-specific PPIase activity. 2006, Pubmed
Li, A putative protein serine/threonine phosphatase from Plasmodium falciparum contains a large N-terminal extension and five unique inserts in the catalytic domain. 1998, Pubmed
Li, Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney. 1995, Pubmed
Li, Protein phosphatase beta, a putative type-2A protein phosphatase from the human malaria parasite Plasmodium falciparum. 1997, Pubmed
Lindenthal, Identification and biochemical characterisation of a protein phosphatase 5 homologue from Plasmodium falciparum. 2002, Pubmed
Longin, An inactive protein phosphatase 2A population is associated with methylesterase and can be re-activated by the phosphotyrosyl phosphatase activator. 2004, Pubmed
López-Barragán, Directional gene expression and antisense transcripts in sexual and asexual stages of Plasmodium falciparum. 2011, Pubmed
Lorca, Constant regulation of both the MPF amplification loop and the Greatwall-PP2A pathway is required for metaphase II arrest and correct entry into the first embryonic cell cycle. 2010, Pubmed , Xenbase
Magnusdottir, The crystal structure of a human PP2A phosphatase activator reveals a novel fold and highly conserved cleft implicated in protein-protein interactions. 2006, Pubmed
Mamoun, Plasmodium protein phosphatase 2C dephosphorylates translation elongation factor 1beta and inhibits its PKC-mediated nucleotide exchange activity in vitro. 2001, Pubmed
Mamoun, Identification and characterization of an unusual double serine/threonine protein phosphatase 2C in the malaria parasite Plasmodium falciparum. 1998, Pubmed
Manning, The protein kinase complement of the human genome. 2002, Pubmed
Mitchell, The phosphotyrosyl phosphatase activator, Ncs1p (Rrd1p), functions with Cla4p to regulate the G(2)/M transition in Saccharomyces cerevisiae. 2001, Pubmed
Mochida, Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis. 2010, Pubmed , Xenbase
Patzewitz, An ancient protein phosphatase, SHLP1, is critical to microneme development in Plasmodium ookinetes and parasite transmission. 2013, Pubmed
Philip, A unique Kelch domain phosphatase in Plasmodium regulates ookinete morphology, motility and invasion. 2012, Pubmed
Pieper, ModBase, a database of annotated comparative protein structure models, and associated resources. 2011, Pubmed
Rempola, Functional analysis of RRD1 (YIL153w) and RRD2 (YPL152w), which encode two putative activators of the phosphotyrosyl phosphatase activity of PP2A in Saccharomyces cerevisiae. 2000, Pubmed
Sacco, The human phosphatase interactome: An intricate family portrait. 2012, Pubmed
Sidhu, pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. 2005, Pubmed
Singh, Role of calcineurin and actin dynamics in regulated secretion of microneme proteins in Plasmodium falciparum merozoites during erythrocyte invasion. 2014, Pubmed
Smetana, Interaction analysis of the heterotrimer formed by the phosphatase 2A catalytic subunit, alpha4 and the mammalian ortholog of yeast Tip41 (TIPRL). 2007, Pubmed
Tamura, MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. 2011, Pubmed
Trager, Human malaria parasites in continuous culture. 1976, Pubmed
Treeck, The phosphoproteomes of Plasmodium falciparum and Toxoplasma gondii reveal unusual adaptations within and beyond the parasites' boundaries. 2011, Pubmed
Umlas, New thick-film technique for malaria diagnosis. Use of saponin stromatolytic solution for lysis. 1971, Pubmed
Van Hoof, Functional analysis of conserved domains in the phosphotyrosyl phosphatase activator. Molecular cloning of the homologues from Drosophila melanogaster and Saccharomyces cerevisiae. 1998, Pubmed
Van Hoof, Specific interactions of PP2A and PP2A-like phosphatases with the yeast PTPA homologues, Ypa1 and Ypa2. 2005, Pubmed
Van Hoof, The Saccharomyces cerevisiae phosphotyrosyl phosphatase activator proteins are required for a subset of the functions disrupted by protein phosphatase 2A mutations. 2001, Pubmed
Van Hoof, The Saccharomyces cerevisiae homologue YPA1 of the mammalian phosphotyrosyl phosphatase activator of protein phosphatase 2A controls progression through the G1 phase of the yeast cell cycle. 2000, Pubmed
Vernes, Plasmodium falciparum strain-specific human antibody inhibits merozoite invasion of erythrocytes. 1984, Pubmed
Vicogne, Conservation of epidermal growth factor receptor function in the human parasitic helminth Schistosoma mansoni. 2004, Pubmed , Xenbase
Yokoyama, Modulation of the growth of Plasmodium falciparum in vitro by protein serine/threonine phosphatase inhibitors. 1998, Pubmed